OrbiMed Advisors LLCs Strategic Acquisition of Verastem Inc Shares
| ZHCLF Stock | USD 0.0001 0.00 0.00% |
Roughly 81 percent of all Zenith Capital's stockholders are aggressively thinking of buying. The analysis of overall sentiment of trading Zenith Capital Corp pink sheet suggests that a large number of investors are excited at this time. The current market sentiment, together with Zenith Capital's historical and current headlines, can help investors time the market. In addition, many technical investors use Zenith Capital Corp stock news signals to limit their universe of possible portfolio assets.
Zenith Capital pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Zenith daily returns and investor perception about the current price of Zenith Capital Corp as well as its diversification or hedging effects on your existing portfolios.
Zenith |
Overview of the Recent Transaction On September 30, 2024, OrbiMed Advisors LLC, a prominent investment firm, significantly increased its stake in Verastem Inc
Read at gurufocus.com
 |
Zenith Capital Fundamental Analysis
We analyze Zenith Capital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zenith Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zenith Capital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
Zenith Capital is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Zenith Capital Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zenith Capital pink sheet to make a market-neutral strategy. Peer analysis of Zenith Capital could also be used in its relative valuation, which is a method of valuing Zenith Capital by comparing valuation metrics with similar companies.
Peers
Zenith Capital Related Equities
| BPMC | Blueprint Medicines | 6.80 | ||||
| INBX | Inhibrx | 5.16 | ||||
| LXRX | Lexicon Pharmaceuticals | 4.48 | ||||
| MCRB | Seres Therapeutics | 4.11 | ||||
| PRTG | Portage Biotech | 3.92 | ||||
| AMLX | Amylyx Pharmaceuticals | 3.80 | ||||
| ELVN | Enliven Therapeutics | 3.37 | ||||
| ARVN | Arvinas | 2.55 | ||||
| FENC | Fennec Pharmaceuticals | 2.18 | ||||
| HOPHF | Hemogenyx Pharmaceuticals | 0.00 | ||||
| CMVLF | Cellectis | 0.00 | ||||
| CELC | Celcuity LLC | 0.74 | ||||
| PLX | Protalix Biotherapeutics | 2.10 | ||||
| PMN | ProMIS Neurosciences | 4.05 | ||||
| CVALF | Covalon Technologies | 5.15 | ||||
| IOVA | Iovance Biotherapeutics | 19.39 |
Complementary Tools for Zenith Pink Sheet analysis
When running Zenith Capital's price analysis, check to measure Zenith Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zenith Capital is operating at the current time. Most of Zenith Capital's value examination focuses on studying past and present price action to predict the probability of Zenith Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zenith Capital's price. Additionally, you may evaluate how the addition of Zenith Capital to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |